Potential mechanisms of prospective antimigraine drugs: A focus on vascular (side) effects
Keywords: N-NITRO-L-آرژینین متیل استر (L-NAME); Antimigraine drugs; Neuropeptides; 5-HT1B/1D receptor agonists; CGRP receptor antagonists; Migraine; Vascular side-effects; AMPA; α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CGRP; Calcitonin gene-related peptide; CNS; Central nervous system; CS